You have spoken directly to researchers involved in a clinical trial. Did they give you insights?
:)
From what I can see the ownership trail is murky at best, as is the financing. I think it's all blather, but I don't care because it was a golden short for me.
Tell me some more about your conversations with the researchers at U Mn. Who were they, specifically? You spoke with more than one since you said researchers.
What apparent progress? What do you think about the first set of data released?